Correction: Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
BMJ Publishing Group
2021-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/9/10/e001932corr1.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantitation of Phosphotyrosine Signals in Human Prostate Cell Adhesion Sites
by: Anne E. Cress
Published: (2000-10-01) -
The Role of Aryl Hydrocarbon Receptor and Crosstalk with Estrogen Receptor in Response of Breast Cancer Cells to the Novel Antitumor Agents Benzothiazoles and Aminoflavone
by: Mariana A. Callero, et al.
Published: (2011-01-01) -
Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists.
by: Sreenivasan Paruthiyil, et al.
Published: (2009-07-01) -
The expression and localization of estrogen receptor beta in hyperplastic and neoplastic prostate lesions
by: Fejsa-Levakov Aleksandra, et al.
Published: (2015-01-01) -
Role of Estrogen Receptor Signaling in Breast Cancer Metastasis
by: Sudipa Saha Roy, et al.
Published: (2012-01-01)